Desensitization to lenograstim after a life- threatening reaction to filgrastim

J Investig Allergol Clin Immunol. 2015;25(2):158-60.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Allergic Agents / therapeutic use
  • Antineoplastic Agents / adverse effects
  • Cross Reactions
  • Desensitization, Immunologic / methods*
  • Drug Hypersensitivity / diagnosis
  • Drug Hypersensitivity / etiology
  • Drug Hypersensitivity / immunology
  • Drug Hypersensitivity / prevention & control*
  • Female
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / administration & dosage*
  • Granulocyte Colony-Stimulating Factor / adverse effects*
  • Granulocyte Colony-Stimulating Factor / immunology
  • Humans
  • Hypersensitivity, Immediate / chemically induced
  • Hypersensitivity, Immediate / diagnosis
  • Hypersensitivity, Immediate / immunology
  • Hypersensitivity, Immediate / prevention & control*
  • Immune Tolerance
  • Intradermal Tests
  • Lenograstim
  • Neutropenia / chemically induced
  • Neutropenia / drug therapy*
  • Predictive Value of Tests
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / immunology
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Anti-Allergic Agents
  • Antineoplastic Agents
  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Lenograstim
  • Filgrastim